If someone you love is struggling to stop, compassionate guidance can bridge resistance and safety, and you can explore drug intervention support to start that process
As of mid-2025, retatrutide is not approved for clinical use in the United Kingdom
Many of the properties and benefits sought by GLP-1 users have wider appeal and could set the tone for healthy NPD for the foreseeable future
The metabolic amplification may increase both benefits and side effects
Losing more than 10% of your body weight can help reduce sleep apnea symptoms
Employers have a real opportunity to step in, offer these treatments affordably and with dignity, and position themselves as employers of choice. While weighing the choice to cover GLP-1s, employer cost is a significant consideration, Midlam noted